InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,018.39
(
-0.34%
)
US TECH 100
16,860.80
(
0.00%
)
Dow Jones
37,903.29
(
0.23%
)
Brent Oil
84.00
(
0.55%
)
Bitcoin
57,704.81
(
-0.92%
)

Replies to post #42811 on MultiCell Technologies Inc (MCET)

Replies to #42811 on MultiCell Technologies Inc (MCET)

TPX

07/06/17 11:41 AM

#42817 RE: TPX #42811

Oxis and MultiCell's MultiCell Immunotherapeutics partnered to develop ADCs using Oxis' OXS-2175 for triple-negative breast cancer (TNBC) and OXS-4235 for multiple myeloma (MM)

http://bciq.biocentury.com/deals/deal_427639